Medical Cannabis in Serbia: The Survey of Knowledge and Attitudes in an Urban Adult Population

Journal of Psychoactive Drugs

Volumn 49, Issue 3, 2017, Pages 217-224

  Gazibara, Tatjana ^a   Prpic, Milica ^a   Maric, Gorica ^a   Pekmezovic, Tatjana ^a   Kisic Tepavcevic, Darija ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Attitude; cannabis; knowledge; medical; public

Indexed keywords

MEDICAL CANNABIS;

ADULT; AGED; ANEMIA; ANXIETY; ARTICLE; ASTHMA; ATTITUDE; BLEEDING; BLURRED VISION; CATARACT; CONSTIPATION; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DIZZINESS; FEMALE; HALLUCINATION; HUMAN; INSOMNIA; KNOWLEDGE; LIKERT SCALE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MEMORY DISORDER; NAUSEA; PARANOIA; QUESTIONNAIRE; RISK FACTOR; SEIZURE; SERBIA; SMOKING; TACHYCARDIA; URBAN POPULATION; ADOLESCENT; ATTITUDE TO HEALTH; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICAL MARIJUANA; MIDDLE AGED; SERBIA; URBAN POPULATION; YOUNG ADULT;

EID: 85014473055     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2017.1292434     Document Type: Article

References (33)

1. 23 Legal Medical Marijuana States and DC. n.d. Laws, Fees, and Possession Limits. http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881 (accessed November 10, 2015).
2. Albertson, T. E., J. A., Chenoweth, D. K., Colby, and M. E., Sutter. 2016. The changing drug culture:Medical and recreational marijuana. FP Essentials 441:11–17.
3. Balkan Insight. 2015. Croatia legalizes marijuana for medical use. http://www.balkaninsight.com/en/article/croatia-first-balkan-county-to-legalize-medical-marijuana-10-15-2015-1 (accessed October 23, 2015).
4. Basu, S., A., Ray, and B. N., Dittel. 2011. Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses. The Journal of Immunology 187 (11):5720–32. doi:10.4049/jimmunol.1102195.
5. Birdsall, S. M., T. C., Birdsall, and L. A., Tims. 2016. The use of medical marijuana in cancer. Current Oncology Reports 18 (7):40. doi:10.1007/s11912-016-0530-0.
6. Carlini, B. H., S. B., Garrett, and G. T., Carter. 2017. Medicinal cannabis:A survey among health care providers in Washington state. American Journal of Hospice and Palliative Care 34 (1):85–91. doi:10.1177/1049909115604669.
7. Charuvastra, A., P. D., Friedmann, and M. D., Stein. 2005. Physician attitudes regarding the prescription of medical marijuana. Journal of Addictive Disorders 24 (3):87–93. doi:10.1300/J069v24n03_07.
8. Dormann, C. F., J., Elith, S., Bacher, S., Bacher, C., Buchmann, G., Carl, G., Carré, J. R., García Marquéz, B., Gruber, B., Lafourcade, P. J., Leitão, T., Münkemüller, C., McClean, P. E., Osborne, B., Reineking, B., Schröder, A. K., Skidmore, D., Zurell, and S., Lautenbach. 2013. Collinearity:A review of methods to deal with it and a simulation study evaluating their performance. Ecography 36:27–46. doi:10.1111/j.1600-0587.2012.07348.x.
9. Ebert, T., Y., Zolotov, S., Eliav, O., Ginzburg, I., Shapira, and R., Magnezi. 2015. Assessment of Israeli physicians’ knowledge, experience and attitudes towards medical cannabis:A pilot study. Israel Medical Association Journal 17 (7):437–41.
10. European Monitoring Centre for Drugs and Drug Addiction. 2009. Serbia:Country overview. http://www.emcdda.europa.eu/system/files/publications/531/CO_Serbia_202235.pdf.
11. Global Burden of Disease Cancer Collaboration. 2015. The global burden of cancer 2013. Journal of the American Medical Association Oncology 1 (4):505–27.
12. Grotenherman, F., 2003. Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics 42:327–60. doi:10.2165/00003088-200342040-00003.
13. Grotenhermen, F. C., 2005. Cannabinoids. Current Drug Targets - CNS & Neurological Disorders 4:507–30.
14. Hosmer, D. W., and S., Lemeshow. 2000. Applied logistic regression, 2nd ed. New York, NY:Wiley, Inc.
15. InSerbia Network Foundation. 2014. Serbia could soon legalize marijuana:Report. http://inserbia.info/today/2014/09/serbia-could-soon-legalize-marijuana-report/.
16. Kolena, B., I., Petrovičová, T., Trnovec, T., Pilka, and G., Bičanová. 2016. Marijuana:Views on its medical use recorded at the Slovak social network. Journal of Drug Education. Advance online publication. doi:10.1177/0047237916646442.
17. Kondrad, E., and A., Reid. 2013. Colorado family physicians’ attitudes toward medical marijuana. The Journal of the American Board of Family Medicine 26:52–60. doi:10.3122/jabfm.2013.01.120089.
18. Manzanares, J., M., Julian, and A., Carrascosa. 2006. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Current Neuropharmacology 4 (3):239–57. doi:10.2174/157015906778019527.
19. Markovic-Denic, L., A., Cirkovic, S., Zivkovic, D., Stanic, and V., Skodric-Trifunovic. 2014. Cancer mortality in central Serbia. Journal of Balkan Union of Oncology 19 (1):273–77.
20. Mechoulam, R., and L. A., Parker. 2013. The endocannabinoid system and the brain. Annual Review of Psychology 64:21–47. doi:10.1146/annurev-psych-113011-143739.
21. Metts, J., S., Wright, J., Sundaram, and N., Hashemi. 2016. Medical marijuana:A treatment worth trying? Journal of Family Practice 65 (3):178–85.
22. Moeller, K., and B., Woods. 2015. Pharmacy students’ knowledge and attitudes regarding medical marijuana. American Journal of Pharmacy Education 79 (6):85. doi:10.5688/ajpe79685.
23. Parmar, J. R., B. D., Forrest, and R. A., Freeman. 2016. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Research in Social and Administrative Pharmacy 12 (4):638–54. doi:10.1016/j.sapharm.2015.09.002.
24. Rubens, M., 2014. Political and medical views on medical marijuana and its future. Social Work in Public Health 29 (2):121–31. doi:10.1080/19371918.2013.821351.
25. Suerken, C. K., B. A., Reboussin, E. L., Sutfin, K. G., Wagoner, J., Spangler, and M., Wolfson. 2014. Prevalence of marijuana use at college entry and risk factors for initiation during freshman year. Addictive Behavior 39 (1):302–07. doi:10.1016/j.addbeh.2013.10.018.
26. Svízenská, I., P., Dubový, and A., Sulcová. 2008. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures–a short review. Pharmacology Biochemistry and Behavior 90 (4):501–11. doi:10.1016/j.pbb.2008.05.010.
27. Sznitman, S. R., and A. L., Bretteville-Jensen. 2015. Public opinion and medical cannabis policies:Examining the role of underlying beliefs and national medical cannabis policies. Harm Reduction Journal 12:46. doi:10.1186/s12954-015-0082-x.
28. Volkow, N. D., R. D., Baler, W. M., Compton, and S. R. B., Weiss. 2014. Adverse health effects of marijuana use. New England Journal of Medicine 370 (23):2219–27. doi:10.1056/NEJMra1402309.
29. Wagner, G. A., V. A., Stempliuk, M. L., Zilberman, L. P., Barroso, and A. G., Andrade. 2007. Alcohol and drug use among university students:Gender differences. Revista Brasileira de Psiquiatria 29:123–29. doi:10.1590/S1516-44462006005000033.
30. WHO Regional Office for Europe. 2010. Evaluation of the organization and provision of primary care in Serbia:Primary care in the WHO European region. http://www.euro.who.int/__data/assets/pdf_file/0005/128849/e94554.pdf (accessed October 30, 2015).
31. Wilkie, G., B., Sakr, and T., Rizack. 2016. Medical marijuana use in oncology:A review. JAMA Oncology. Advance online publication. doi:10.1001/jamaoncol.2016.0155.
32. Wilkinson, S. T., R., Radhakrishnan, and D. C., D’Souza. 2016. A systematic review of the evidence for medical marijuana in psychiatric indications. The Journal of Clinical Psychiatry 77 (8):1050–64. doi:10.4088/JCP.15r10036.
33. Ziemianski, D., R., Capler, R., Tekanoff, A., Lacasse, F., Luconi, and M. A., Ware. 2015. Cannabis in medicine:A national educational needs assessment among Canadian physicians. BMC Medical Education 15:52. doi:10.1186/s12909-015-0335-0.